Trials / Completed
CompletedNCT01076153
Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR
A Multi-center, Post-Marketing Observational Study to Identify the Recovery Time in Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 760 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that Klacid modified release (MR) shortens symptom recovery time in Thai patients with upper or lower respiratory tract infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clarithromycin (Klacid® MR) | Klacid MR 500mg (clarithromycin) |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2010-02-26
- Last updated
- 2011-07-12
- Results posted
- 2011-06-29
Locations
26 sites across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01076153. Inclusion in this directory is not an endorsement.